Robin Condliffe
Impact in
- Pulmonary and Respiratory Medicine top 0.1%
- Pulmonary Hypertension Research and Treatments
- Internal Medicine top 1%
- Venous Thromboembolism Diagnosis and Management
Papers in
-
- Pulmonary Hypertension Research and Treatments 163
-
- Venous Thromboembolism Diagnosis and Management 10
- Co-authors
- David Gerard Kiely (118 shared papers)Charlie A Elliot (60 shared papers)Andrew J. Swift (61 shared papers)Jim M. Wild (47 shared papers)Smitha Rajaram (41 shared papers)David A. Capener (32 shared papers)Judith A. Hurdman (35 shared papers)Martin R. Wilkins (7 shared papers)
- Journals
- European Respiratory Journal (22 papers)Thorax (16 papers)Pulmonary Circulation (13 papers)American Journal of Respiratory and Critical Care Medicine (10 papers)Radiology (7 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Robin Condliffe
198 papers receiving 14.8k citations
Robin Condliffe's Hit Papers
Peers
Comparison fields: 5 of 129
- Pulmonary and Respiratory Medicine 9.7k
- Internal Medicine 473
- Infectious Diseases 1.4k
- Health Informatics 135
- Cardiology and Cardiovascular Medicine 1.3k
Countries citing papers authored by Robin Condliffe
This map shows the geographic impact of Robin Condliffe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin Condliffe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin Condliffe more than expected).
Fields of papers citing papers by Robin Condliffe
This network shows the impact of papers produced by Robin Condliffe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin Condliffe. The network helps show where Robin Condliffe may publish in the future.
Co-authors
The 25 scholars most cited alongside Robin Condliffe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 207 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension Hit paper breakdown → | 2022 | 2388 |
| 2 | Definitions and Diagnosis of Pulmonary Hypertension Hit paper breakdown → | 2013 | 1414 |
| 3 | Connective Tissue Disease–associated Pulmonary Arterial Hypertension in the Modern Treatment Era Hit paper breakdown → | 2008 | 532 |
| 4 | Changing Demographics, Epidemiology, and Survival of Incident Pulmonary Arterial Hypertension: Results from the Pulmonary Hypertension Registry of the United Kingdom and Ireland Hit paper breakdown → | 2012 | 473 |
| 5 | Whole-genome sequencing of patients with rare diseases in a national health system Hit paper breakdown → | 2020 | 418 |
| 6 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 411 |
| 7 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 393 |
| 8 | ASPIRE registry: Assessing the Spectrum of Pulmonary hypertension Identified at a REferral centre Hit paper breakdown → | 2011 | 376 |
| 9 | 2008 | 330 | |
| 10 | Dynamic Risk Stratification of Patient Long-Term Outcome After Pulmonary Endarterectomy Hit paper breakdown → | 2016 | 321 |
| 11 | Identification of rare sequence variation underlying heritable pulmonary arterial hypertension Hit paper breakdown → | 2018 | 294 |
| 12 | 2020 | 287 | |
| 13 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 14 | 2017 | 255 | |
| 15 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 231 |
| 16 | 2021 | 213 | |
| 17 | 2012 | 203 | |
| 18 | 2020 | 179 | |
| 19 | 2019 | 178 | |
| 20 | 2019 | 157 |
About Robin Condliffe
Robin Condliffe is a scholar working on Pulmonary and Respiratory Medicine, Internal Medicine, Infectious Diseases, Cardiology and Cardiovascular Medicine and Genetics, having authored 207 papers that have together received 15.2k indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (163 papers), COVID-19 Clinical Research Studies (11 papers), Venous Thromboembolism Diagnosis and Management (10 papers), Congenital Heart Disease Studies (8 papers), Cardiac Imaging and Diagnostics (4 papers), Vascular Anomalies and Treatments (4 papers), Artificial Intelligence in Healthcare and Education (3 papers) and Cardiovascular Issues in Pregnancy (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (9.7k citations), Internal Medicine (473 citations), Infectious Diseases (1.4k citations), Health Informatics (135 citations) and Cardiology and Cardiovascular Medicine (1.3k citations). Robin Condliffe has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include David Gerard Kiely, Charlie A Elliot, Andrew J. Swift, Jim M. Wild, Smitha Rajaram, David A. Capener, Judith A. Hurdman, Martin R. Wilkins, David Langleben and David B. Badesch. Their work appears in journals such as European Respiratory Journal, Thorax, Pulmonary Circulation, American Journal of Respiratory and Critical Care Medicine and Radiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.